Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 1;12(4):1036-1042.
doi: 10.14336/AD.2021.0423. eCollection 2021 Jul.

A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment

Affiliations
Review

A Review of Insomnia Treatments for Patients with Mild Cognitive Impairment

Meghan K Mattos et al. Aging Dis. .

Abstract

Mild cognitive impairment (MCI) impacts approximately 20% of older adults, with many also experiencing sleep disorders, such as insomnia. Given the relationship between sleep and dementia, addressing sleep issues may offer an opportunity to treat reversible causes. There are two primary treatments for insomnia: behavioral-based (cognitive behavioral therapy for insomnia, CBT-I) and pharmacological interventions. Although CBT-I is recommended as first-line treatment for insomnia in older adults, sedative-hypnotics are more likely to be recommended than non-pharmacological treatments given their convenience and accessibility. However, there are significant concerns in prescribing medications to patients with MCI. To explore this disconnect, we reviewed insomnia treatments in older adults with MCI studies and current guidelines of pharmacological therapy. First, we reviewed studies presenting non-pharmacological treatment of insomnia in older adults with MCI. Although the search yielded over 4,000 non-duplicate titles, only one article presented data on non-pharmacological treatment of insomnia in MCI. The literature covering comorbid insomnia, CBT-I, and MCI is sparse. In contrast to review of non-pharmacological studies, studies on the pharmacological treatment of insomnia in older adults were ample. Finally, we reviewed international guidelines for pharmacological treatment of insomnia in cognitive disorders. More widely used pharmacological interventions show short-term effectiveness with problems of recurrence, ineffectiveness in inadvertent or purposeful chronic use, and adverse side effects. Despite evidence regarding adverse consequences, pharmacological treatment of insomnia remains the most common treatment for insomnia. Reflecting on age-related changes in older adults, particularly those with MCI, inappropriate or mismanagement of medication can lead to unnecessary complications. Further research examining effective behavioral-based sleep management options in older adults with cognitive impairment is needed with exploration of improved sleep on cognitive function.

Keywords: cognitive behavioral therapy; cognitive dysfunction; sleep; sleep initiation and maintenance disorders.

PubMed Disclaimer

Conflict of interest statement

Competing interests Dr. Lee Ritterband has the following financial disclosures: BeHealth Solutions and Pear Therapeutics, two companies that develop and disseminate digital therapeutics, including by licensing the therapeutic developed, based in part, on early versions of the software utilized in research reported. These companies had no role in preparing this manuscript. Dr. Ritterband is also a consultant to Mahana Therapeutics, a separate digital therapeutic company not affiliated with this research. The terms of these arrangements have been reviewed and approved by the University of Virginia in accordance with its policies.

References

    1. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al.. (2011). Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging and the Alzheimer’s Association workgroup. Alzheimer’s Dement, 7:1-13. - PMC - PubMed
    1. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L (2004). Mild cognitive impairment - beyond controversies , towards a consensus?: report of the International Working Group on Mild Cognitive Impairment. J Intern Med, 256:240-246. - PubMed
    1. Farias ST, Mungas D, Reed BR, Harvey D, DeCarli C (2009). Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol, 66:1151-7. - PMC - PubMed
    1. Petersen RC (2016). Mild Cognitive Impairment. Clin Geriatr Med, 33:325-337 - PubMed
    1. Yulug B, Hanoglu L, Kilic E (2017). Does sleep disturbance affect the amyloid clearance mechanisms in Alzheimer’s disease? Psychiatry Clin Neurosci, 71:673-677. - PubMed

LinkOut - more resources